131064-75-0
Chemical Structure
(R,R)-Benazepril
- CAS No.: 131064-75-0
- Formula:C24H28N2O5
- Molecular Weight:424.50
IUPAC Name: 2-((R)-3-(((R)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetic acid
InChIKey: XPCFTKFZXHTYIP-WOJBJXKFSA-N
SMILES: C(C(O)=O)N1C=2C(CC[C@@H](N[C@H](CCC3=CC=CC=C3)C(OCC)=O)C1=O)=CC=CC2
Biological Activity: (R,R)-Benazepril is the R configuration of Benazepril (HY-B0093). Benazepril (CGS14824A free base) is an orally active angiotensin-converting enzyme (ACE) inhibitor that reduces the production of angiotensin II. Benazepril inhibits oxidative stress and suppresses apoptosis through the PI3K/Akt signaling pathway. Benazepril effectively ameliorates diabetic nephropathy and reduces proteinuria. Benazepril is used in the study of hypertension, heart failure, and diabetic nephropathy[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
(R,R)-Benazepril | (R,R)-Benazepril is the R configuration of Benazepril (HY-B0093). Benazepril (CGS14824A free base) is an orally active angiotensin-converting enzyme (ACE) inhibitor that reduces the production of angiotensin II. Benazepril inhibits oxidative stress and suppresses apoptosis through the PI3K/Akt signaling pathway. Benazepril effectively ameliorates diabetic nephropathy and reduces proteinuria. Benazepril is used in the study of hypertension, heart failure, and diabetic nephropathy. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Hou FF, et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med. 2006 Jan 12;354(2):131-40. [Content Brief]
- [2]. Huang XM, et al. Effects of chronotherapy of benazepril on the diurnal profile of RAAS and clock genes in the kidney of 5/6 nephrectomy rats. J Huazhong Univ Sci Technolog Med Sci. 2013 Jun;33(3):368-74. [Content Brief]
